Manasa Suresh

Georgetown University — United States

Medicine · Health Sciences

11h-index394citations43works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(22), Hepatitis C virus research(17), Liver Disease Diagnosis and Treatment(8), Histone Deacetylase Inhibitors Research(8), Peptidase Inhibition and Analysis(8)

Publications43 total

Abstract 2187: Functional classification of tumor-associated macrophages and changes in TAM subpopulations in response to various immunotherapies
Cancer Research·2025
Abstract 2253: HDAC6 inhibitors reprogram macrophages in antitumor-adoptive cell therapy
Cancer Research·2025
Abstract 7277: Development of a macrophage-based screening pipeline to evaluate the immunomodulatory effects of small molecule inhibitors
Cancer Research·2025
Abstract 2148: HDAC6 inhibitors modulate macrophage functional activity in the post-radiotherapy tumor microenvironment
Cancer Research·2025
Abstract 3144: Selective HDAC10 inhibitor enhances innate antitumor immunity
Cancer Research·2025
Abstract 6139: Changes in macrophage phenotype and function with aging affects tumor growth and tumor microenvironment in murine cancer models
Cancer Research·2025
Abstract 4216: Advancing cancer immunotherapy through the development of a novel selective HDAC6 inhibitors
Cancer Research·2025
The HDAC6 inhibitor AVS100 (SS208) induces a pro-inflammatory tumor microenvironment and potentiates immunotherapy
Science Advances·2024· 21 citedOpen Access
Advancing Opthalmic Diagnostics: U-Net for Retinal Blood Vessel Segmentation
International Journal of Innovative Science and Research Technology (IJISRT)·2024· 1 citedOpen Access
Abstract 1421: The HDAC6-specific inhibitor AVS100 (SS208) blocks M2 polarization of tumor associated macrophages and potentiates immunotherapy in preclinical tumor models
Cancer Research·2024
Abstract 4583: Development of selective HDAC6 inhibitors to improve cancer immunotherapy
Cancer Research·2024
Abstract 2688: Age-associated changes in macrophage function and phenotype affects cancer development, and the efficacy of macrophage targeted anticancer therapies in murine melanoma model
Cancer Research·2024
Abstract 1122: Inhibition of HDAC6 enhanced radiation therapy induced antitumor response in melanoma
Cancer Research·2024
Abstract 5247: Reprogramming tumor microenvironment with intratumor macrophage adoptive cell therapy in melanoma
Cancer Research·2024
The advances in targeting CD47/SIRPα “do not eat me” axis and their ongoing challenges as an anticancer therapy
Oncotarget·2024· 4 citedOpen Access
Identification of novel tetrahydroquinoxaline derived phenyl ureas as modulators of the hepatitis B virus nucleocapsid assembly
European Journal of Medicinal Chemistry·2023· 3 citedOpen Access
Abstract 666: Targeting the CD47/SIRPα “Do not eat me” phagocytic pathway in macrophages to improve anti-CD47 immune therapy
Cancer Research·2023· 2 cited
Abstract 2880: Inhibition of HDAC6 and HDAC11 has opposite effects on inflammation and the modulation of the functional phenotype of macrophages in the tumor microenvironment
Cancer Research·2023· 1 cited
Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B
Viruses·2022· 14 citedOpen Access
Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B
Frontiers in Immunology·2022· 7 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Stephan Menne(21), Satish Noonepalle(15), Alejandro Villagra(12), Xintang Li(12), Kyle Korolowicz(10), Changsuek Yon(9), Bhaskar Kallakury(9), Nithya Gajendran(9), David Quiceno-Torres(8), Karen Tan(8), Marta G. Murreddu(7), Robin D. Tucker(6), Bin Li(6), Xu Huang(5), Karthik Musunuri(5), Radhakrishnan P. Iyer(4), Seetharamaiyer Padmanabhan(4), Moraima Jiménez(4), Severin O. Gudima(4), Nithya Gajendran(4)